Citation: Cy. Hsu et Bym. Yung, DOWN-REGULATION OF NUCLEOPHOSMIN B23 DURING RETINOIC ACID-INDUCED DIFFERENTIATION OF HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS/, Oncogene, 16(7), 1998, pp. 915-923
Citation: Cc. Chou et Bym. Yung, ANTIAPOPTOTIC EFFECT OF RAS IN THE APOPTOSIS INDUCED BY SERUM DEPRIVATION AND EXPOSURE TO ACTINOMYCIN-D, Naunyn-Schmiedeberg's archives of pharmacology, 355(2), 1997, pp. 177-182
Citation: Yy. Lu et al., DECREASED ACCUMULATION AND DEPHOSPHORYLATION OF THE MITOSIS-SPECIFIC FORM OF NUCLEOPHOSMIN B23 IN STAUROSPORINE-INDUCED CHROMOSOME DECONDENSATION/, Biochemical journal, 317, 1996, pp. 321-327
Citation: Iw. Yang et al., DOSE-DEPENDENT EFFECTS OF BERBERINE ON CELL-CYCLE PAUSE AND APOPTOSISIN BALB C 3T3 CELLS/, Naunyn-Schmiedeberg's archives of pharmacology, 354(2), 1996, pp. 102-108
Citation: St. Chang et Bym. Yung, POTENTIATION OF SODIUM BUTYRATE-INDUCED APOPTOSIS BY VANADATE IN HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE HL-60, Biochemical and biophysical research communications, 221(3), 1996, pp. 594-601
Citation: Cc. Chou et al., INTRACELLULAR ATP IS REQUIRED FOR ACTINOMYCIN D-INDUCED APOPTOTIC CELL-DEATH IN HELA-CELLS, Cancer letters, 96(2), 1995, pp. 181-187
Citation: Cl. Kuo et al., BERBERINE COMPLEXES WITH DNA IN THE BERBERINE-INDUCED APOPTOSIS IN HUMAN LEUKEMIC HL-60 CELLS, Cancer letters, 93(2), 1995, pp. 193-200
Citation: L. Wei et Bym. Yung, EFFECTS OF OKADAIC ACID AND VANADATE ON TPA-INDUCED MONOCYTIC DIFFERENTIATION IN HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE HL-60, Cancer letters, 90(2), 1995, pp. 199-205
Citation: Yh. Chou et Bym. Yung, CELL-CYCLE PHASE-DEPENDENT CHANGES OF LOCALIZATION AND OLIGOMERIZATION STATES OF NUCLEOPHOSMIN B23/, Biochemical and biophysical research communications, 217(1), 1995, pp. 313-325
Citation: Mh. Wu et Bym. Yung, CELL-CYCLE PHASE-DEPENDENT CYTOTOXICITY OF ACTINOMYCIN-D IN HELA-CELLS, European journal of pharmacology. Environmental toxicology and pharmacology section, 270(2-3), 1994, pp. 203-212
Citation: Bym. Yung, SPHINGANINE POTENTIATION OF CELLULAR-DIFFERENTIATION INDUCED BY VARIOUS ANTILEUKEMIA DRUGS IN HUMAN LEUKEMIA-CELL LINE HL-60, Naunyn-Schmiedeberg's archives of pharmacology, 350(5), 1994, pp. 575-581
Citation: Bym. Yung et al., SPHINGANINE POTENTIATION OF DIMETHYL SULFOXIDE-INDUCED GRANULOCYTIC DIFFERENTIATION, INCREASE OF ALKALINE-PHOSPHATASE ACTIVITY AND DECREASEOF PROTEIN-KINASE-C ACTIVITY IN A HUMAN LEUKEMIA-CELL LINE (HL-60), Biochemical and biophysical research communications, 199(2), 1994, pp. 888-896
Citation: Lll. Wei et al., ALKALINE-PHOSPHATASE ACTIVITY DURING SPHINGANINE POTENTIATION OF RETINOIC ACID-INDUCED DIFFERENTIATION OF HUMAN PROMYELOCYTIC LEUKEMIA-CELLLINE, HL-60, Life sciences, 52(25), 1993, pp. 2035-2043
Citation: Bym. Yung et Ekw. Hui, DIFFERENTIAL REGULATION OF PROTEIN-KINASE-C ISOENZYMES DURING SPHINGANINE POTENTIATION OF RETINOIC ACID-INDUCED GRANULOCYTIC DIFFERENTIATION IN HUMAN LEUKEMIA HL-60-CELLS, Biochemical and biophysical research communications, 196(3), 1993, pp. 1390-1400